The functions of Ca²⁺/calmodulin-dependent protein kinase II (CaMKII) in diabetes progression

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Hyperglycemia triggers numerous molecular malfunctions, leading to diabetes and affecting multiple organs.
• Diabetes impacts the liver, pancreas, kidneys (nephropathy), eyes (retinopathy), and nervous system (neuropathy) through distinct pathways.
• Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a key enzyme activated by calcium signaling, implicated in various cellular processes.

Purpose of the Study:

• To review the multifaceted roles of CaMKII in different organs.
• To elucidate the impact of diabetes on CaMKII activity and function.
• To understand how CaMKII influences the development and progression of diabetic complications.

Main Methods:

• Literature review of studies investigating CaMKII in diabetes.
• Analysis of molecular pathways involving CaMKII in diabetic pathophysiology.
• Synthesis of current knowledge on CaMKII's organ-specific effects in diabetes.

Main Results:

• CaMKII is activated by increased intracellular calcium levels, a common feature in diabetic conditions.
• CaMKII plays a role in the pancreas, liver, heart, and muscles, influencing metabolic regulation and cellular function.
• Dysregulation of CaMKII contributes to organ damage observed in diabetes, including nephropathy and retinopathy.

Conclusions:

• Understanding CaMKII's complex role in various organs is crucial for comprehending diabetic complications.
• Targeting CaMKII pathways may offer novel therapeutic strategies for managing diabetes and its associated organ damage.
• Further research into CaMKII's specific functions in each affected organ is warranted for developing sustained diabetic treatments.